Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase III trial of Fasenra in nasal polyposis meets coprimary endpoints

Sep. 14, 2020

QBW-251: a CFTR potentiator in phase II for the treatment of COPD

Sep. 14, 2020

Results from a phase IIa POC trial of the oral adenosine A1 receptor antagonist PBF-680

Sep. 9, 2020

First phase I data presented for the neutrophil elastase inhibitor BI-1323495

Sep. 9, 2020

New personalized cystic fibrosis treatment treats Class V mutations

Sep. 9, 2020

Palobiofarma reports promising phase II data on PBF-680 for asthma

Sep. 7, 2020

Beijing Sanyou Liheze Biological Technology discovers potential stem cell therapy for COPD

Sep. 4, 2020

Nocion begins healthy volunteer study of NOC-100 for cough

Sep. 3, 2020

Cartesian initiates first-in-human study of Descartes-30 in patients with ARDS and COVID-19

Sep. 3, 2020

BMS details discovery and preclinical study of pulmonary fibrosis candidate BMS-986278

Aug. 31, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...